This finding, along with the increase in CD8+ T cells, suggests there is an expansion of activated CD8+ T cells, as would be expected if these cells are becoming antigen-experienced following the release of tumour-associated antigens as a result of radiotherapy [35,36]. The gene discussed is CD8A; the disease is neoplasm.